Evaluating central oncology navigation and a new oncology research navigator for cancer care
Navigation and Research: Evaluating the Intervention of Central Navigation and an Oncology Research Navigator (ORN) on Cancer Outcomes and Clinical Trial Enrollment (NAVIGATE Trial)
This study is testing if a new support system for cancer patients can help improve their care experience, focusing on those newly diagnosed with certain types of cancer.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 686 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | UNC Lineberger Comprehensive Cancer Center Academic / other |
| Locations | 1 site (Chapel Hill, North Carolina) |
| Trial ID | NCT06618274 on ClinicalTrials.gov |
What this trial studies
This interventional study assesses the effectiveness of central oncology navigation (SOC) alone and in combination with an oncology research navigator (ORN) embedded in cancer care delivery. It involves two cohorts: one with patients newly diagnosed with genitourinary or thoracic cancers who have not yet experienced the central navigation program, and another with patients from gastrointestinal, hematology, and breast cancer clinics where the program is already implemented. Participants will be evaluated pre- and post-implementation to determine the impact of the navigation services on patient care.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older with a confirmed cancer diagnosis and a new patient appointment at UNC Medical Center.
Not a fit: Patients without internet access or those unable to understand English may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the coordination of cancer care, leading to improved patient outcomes and satisfaction.
How similar studies have performed: Other studies have shown promising results with similar navigation approaches in cancer care, indicating potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: In order to participate in this study a subject must meet all of the eligibility criteria outlined below. * Informed consent obtained to participate in the study and HIPAA authorization for release of personal health information. * Subject is willing and able to comply with study activities based on the judgement of the investigator. * Age ≥ 18 years at the time of consent. * Subject has a new patient appointment for cancer care at a UNC Medical Center and a confirmed cancer diagnosis. Exclusion Criteria: * Lack of internet access. * Inability to understand the English language. * Psychological or other disability resulting in the inability to provide informed consent.
Where this trial is running
Chapel Hill, North Carolina
- UNC Lineberger Comprehensive Cancer Center — Chapel Hill, North Carolina, United States (Recruiting)
Study contacts
- Principal investigator: William A Wood, MD — UNC Lineberger Comprehensive Cancer Center
- Study coordinator: Mireille Leone
- Email: Mireille_Leone@med.unc.edu
- Phone: 919-445-0768
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.